Cost-Effectiveness of Lung Volume Reduction Surgery
|Chronic Obstructive Pulmonary Disease Emphysema||Procedure: Effectiveness of Lung Reduction Therapy||Phase 2|
|Study Design:||Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Cost-Effectiveness of Lung Volume Reduction Surgery|
|Study Completion Date:||March 2000|
Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS.
Evaluate cost-effectiveness of LVRS compared to current therapy for COPD.
This is a case control study in which veterans undergoing LVRS at VA Puget Sound Health Care System (VAPSHCS) are compared to patients with a similar severity of disease at Boise VAMC who are not undergoing LVRS. Changes in health related quality of life are being evaluated using three instruments: the SF-36, the St. George�s Respiratory Questionnaire, and the Quality of Well-Being Scale, the latter to calculate utility associated with different health states. Costs will be determined using utilization data on outpatient visits, medications, oxygen use, inpatient days, radiology tests, laboratory tests, and emergency room visits are being collected for the twelve months before and after surgery. Costs will be calculated according to VA and community standards.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00013156
|United States, Washington|
|VA Puget Sound Health Care System Seattle Division, Seattle, WA|
|Seattle, Washington, United States, 98108|
|Principal Investigator:||Hugh F Huizenga, MD MPH||VA Puget Sound Health Care System Seattle Division, Seattle, WA|
|Principal Investigator:||Stephan D. Fihn, MD MPH||VA Puget Sound Health Care System Seattle Division, Seattle, WA|